Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Vaccine

• Publication date

  2002-01-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0264-410X(01)00428-5PMID 11803087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetics of influenza viruses.

  2002cited by this paper
• Lead Visual Information Specialist

  2001cited by this paper
• ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES. PREVENTION AND CONTROL OF INFLUENZA: RECOMMENDATIONS OF THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES (ACIP)

  2000cited by this paper
• Publicly-funded influenza and pneumococcal immunization programs in Canada: a progress report.

  2000cited by this paper
• Is it time to give influenza vaccine to healthy infants?

  2000cited by this paper
• Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group.

  2000cited by this paper
• Economic Impact of Influenza Vaccination in Preschool Children

  2000cited by this paper
• Prevention and treatment of influenza.

  2000cited by this paper
• Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza

  2000cited by this paper
• Humoral and cell-mediated immunity to vero cell-derived influenza vaccine.

  2000cited by this paper
• Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial.

  2000cited by this paper
• Randomized, placebo-controlled double blind study on the efficacy of influenza immunization on absenteeism of health care workers.

  1999cited by this paper
• Inactivated influenza vaccines prepared in cell culture. Summary and recommendations.

  1999cited by this paper
• Influenza Immunization of Schoolchildren: Can We Interrupt Community Epidemics?

  1999cited by this paper
• Regulatory perspective in the United States on cell cultures for production of inactivated influenza virus vaccines.

  1999cited by this paper
• Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.

  1999cited by this paper
• A Phase I, randomized controlled clinical trial to study the reactogenicity and immunogenicity of a new split influenza vaccine derived from a non-tumorigenic cell line.

  1999cited by this paper
• Safety and immunogenicity of a new influenza vaccine grown in mammalian cell culture.

  1998cited by this paper
• Safe administration of influenza vaccine to patients with egg allergy.

  1998cited by this paper
• An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1998-1999 season.

  1998cited by this paper
• The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children.

  1998cited by this paper
• Immunogenicity and reactogenicity of influenza subunit vaccines produced in MDCK cells or fertilized chicken eggs.

  1997cited by this paper
• Clinical influenza virus and the embryonated Hen's egg

  1993cited by this paper
• Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections

  1989cited by this paper
• Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs.

  1989cited by this paper
• Antigenic Variation Among Type A Influenza Viruses

  1983cited by this paper

• Relative Efficacy, Effectiveness and Safety of Newer and/or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory‐Confirmed Influenza in Individuals Aged 18 years and Over: Update of a Systematic Review

  2025cites this paper
• Efficacy of cell culture-derived influenza vaccines for children: A systematic review and meta-analysis

  2023cites this paper
• Systematic review of the efficacy, effectiveness and safety of cell‐based seasonal influenza vaccines for the prevention of laboratory‐confirmed influenza in individuals ≥18 years of age

  2022cites this paper
• Viruses and Virus-Like Particles in Biotechnology: Fundamentals and Applications

  2019cites this paper
• History and reflection of pandemic influenza

  2018cites this paper
• 31 – Inactivated Influenza Vaccines

  2018cites this paper
• A Functional Food Mixture “Protector” Reinforces the Protective Immune Parameters against Viral Flu Infection in Mice

  2018cites this paper
• Cell culture-derived flu vaccine: Present and future

  2018cites this paper
• Vaccines for preventing influenza in healthy children.

  2018cites this paper
• واکسنها برای پیشگیری از وقوع آنفلوآنزا در کودکان سالم

  2018cites this paper
• A Y161F Hemagglutinin Substitution Increases Thermostability and Improves Yields of 2009 H1N1 Influenza A Virus in Cells

  2017cites this paper
• Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines.

  2015cites this paper
• Recombinant influenza viruses as a vaccine vector for HIV

  2015cites this paper
• Cell Immobilization for the Production of Viral Vaccines

  2015cites this paper
• Cell culture-based influenza vaccines: A necessary and indispensable investment for the future

  2015cites this paper
• Mechanisms of resistance to neuraminidase inhibitors in influenza A viruses and evaluation of combined antiviral therapy

  2015cites this paper
• Vaccines for preventing influenza in healthy adults.

  2014cites this paper
• Safety of Vaccines Used for Routine Immunization in the United States.

  2014cites this paper
• Vaccines for preventing influenza in healthy adults.

  2014cites this paper
• Evaluation of safety and immunogenicity of HNVAC, an MDCK-based H1N1 pandemic influenza vaccine, in Phase I single centre and Phase II/III multi-centre, double-blind, randomized, placebo-controlled, parallel assignment studies.

  2014cites this paper
• Virus Production Under Suspension Conditions

  2014cites this paper
• Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy

  2014cites this paper
• High Yield Production of Influenza Virus in Madin Darby Canine Kidney (MDCK) Cells with Stable Knockdown of IRF7

  2013cites this paper
• A replication-incompetent influenza virus bearing the HN glycoprotein of human parainfluenza virus as a bivalent vaccine.

  2013cites this paper
• Immunogenicity and Safety of an Inactivated Trivalent Split Influenza Virus Vaccine in Young Children with Recurrent Wheezing

  2013cites this paper
• 17 – Inactivated influenza vaccines

  2013cites this paper
• The Immunogenicity and Safety of Inactivated Trivalent Split Influenza Vaccine in

  2013cites this paper
• A Replication-Incompetent PB2-Knockout Influenza A Virus Vaccine Vector

  2012cites this paper
• Évaluation de l'impact de la mutation de résistance à l'oseltamivir (H275Y) sur les capacités réplicatives et la virulence du virus pandémique A(H1N1) pdm09

  2012cites this paper
• Vaccines for preventing influenza in healthy children.

  2012cites this paper
• New Strategies for the Development of H5N1 Subtype Influenza Vaccines

  2012cites this paper
• Safety assessment and immunogenicity of a cell-culture-derived influenza vaccine in adults and elderly subjects over three successive influenza seasons

  2012cites this paper
• Non-Traditional Settings for Influenza Vaccination of Adults

  2012cites this paper
• Assessing the safety of influenza vaccination in specific populations: children and the elderly

  2012cites this paper
• Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production

  2012cites this paper
• New technologies for influenza vaccines

  2012cites this paper
• The future of cell culture-based influenza vaccine production

  2011cites this paper
• Characterization of a recombinant influenza vaccine candidate using complementary LC-MS methods.

  2011cites this paper
• Development and strategies of cell-culture technology for influenza vaccine

  2011cites this paper
• History and evolution of influenza vaccines.

  2011cites this paper
• New strategies for the development of H5N1 subtype influenza vaccines: progress and challenges.

  2011cites this paper
• Strategies for preventing influenza: future perspectives in influenza vaccine technology

  2011cites this paper
• Cell Culture-Derived Influenza Vaccines

  2011cites this paper
• Viruses and Virus-Like Particles in Biotechnology

  2011cites this paper
• Enhanced Growth of Influenza Vaccine Seed Viruses in Vero Cells Mediated by Broadening the Optimal pH Range for Virus Membrane Fusion

  2011cites this paper
• Comparison of egg and high yielding MDCK cell-derived live attenuated influenza virus for commercial production of trivalent influenza vaccine: In vitro cell susceptibility and influenza virus replication kinetics in permissive and semi-permissive cells

  2010cites this paper
• Caveolin-1 influences human influenza A virus (H1N1) multiplication in cell culture

  2010cites this paper
• A new MDCK suspension line cultivated in a fully defined medium in stirred-tank and wave bioreactor.

  2010cites this paper
• Clinical efficacy of cell culture–derived and egg‐derived inactivated subunit influenza vaccines in healthy adults.

  2010cites this paper
• Repository of Eurasian influenza A virus hemagglutinin and neuraminidase reverse genetics vectors and recombinant viruses.

  2010cites this paper
• Bench-to-bedside review: Vaccine protection strategies during pandemic flu outbreaks

  2010cites this paper
• Researchinfluences human influenza A virus (H1N1) multiplication in cell culture

  2010cites this paper
• Designing vaccines for pandemic influenza.

  2009cites this paper
• Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin.

  2009cites this paper
• Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity.

  2009cites this paper
• Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.

  2009cites this paper
• Seasonal influenza vaccines.

  2009cites this paper
• Safety, tolerability and immunogenicity of a mammalian cell-culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial.

  2009cites this paper
• Continuous cell lines as a production system for influenza vaccines

  2009cites this paper
• Adverse events of trivalent influenza vaccine among health care workers in Iran.

  2009cites this paper
• Chapter 27 – Influenza

  2009cites this paper
• Cytokine-bearing Influenza Vaccine: Adjuvant Potential of Membrane-bound Immunomodulators

  2009cites this paper
• Pandemic Influenza Vaccines

  2009cites this paper
• Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture.

  2009cites this paper
• Development of an influenza virus vaccine using the baculovirus-insect cell expression system : implications for pandemic preparedness

  2009cites this paper
• A novel mammalian cell-culture technique for consistent production of a well-tolerated and immunogenic trivalent subunit influenza vaccine.

  2009cites this paper
• Trivalent MDCK cell culture-derived influenza vaccine Optaflu® (Novartis Vaccines)

  2009cites this paper
• Transcutaneous delivery and thermostability of a dry trivalent inactivated influenza vaccine patch

  2008cites this paper
• Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China.

  2008cites this paper
• Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.

  2008cites this paper
• Vaccines against epidemic and pandemic influenza

  2008cites this paper
• FluBlok, a recombinant influenza vaccine.

  2008cites this paper
• Vaccines against epidemic and pandemic influenza.

  2008cites this paper
• Influenza vaccines.

  2008cites this paper
• Vaccines for preventing influenza in healthy children.

  2008cites this paper
• Growth Determinants for H5N1 Influenza Vaccine Seed Viruses in MDCK Cells

  2008cites this paper
• Preclinical Evaluation of Microneedle Technology for Intradermal Delivery of Influenza Vaccines

  2007cites this paper
• Effects of several virucidal agents on inactivation of influenza, Newcastle disease, and avian infectious bronchitis viruses in the allantoic fluid of chicken eggs.

  2007cites this paper
• Emerging Infectious Diseases

  2007influential citation
• Establishment of Canine RNA Polymerase I-Driven Reverse Genetics for Influenza A Virus: Its Application for H5N1 Vaccine Production

  2007cites this paper
• Vaccines for preventing influenza in healthy adults.

  2007cites this paper
• Needle-Free Skin Patch Delivery of a Vaccine for a Potentially Pandemic Influenza Virus Provides Protection against Lethal Challenge in Mice

  2007cites this paper
• Confronting Potential Influenza A (H5N1) Pandemic with Better Vaccines

  2007cites this paper
• Search for additional influenza virus to cell interactions

  2006cites this paper
• New viral vaccines.

  2006cites this paper
• Intradermal Immunoadjuvant Noninflammatory Broad Spectrum GM 1 Binding-Deficient Exotoxin Is a Potent Ellingsworth and

  2006cites this paper
• The molecular basis of differences in the receptor-binding properties of antigenically distinct influenza haemagglutinins.

  2006cites this paper
• Vaccine manufacturing: challenges and solutions

  2006cites this paper
• GM1 Binding-Deficient Exotoxin Is a Potent Noninflammatory Broad Spectrum Intradermal Immunoadjuvant

  2006cites this paper
• Vaccins contre la grippe avec adjuvants incluant des agents induits par cytokine

  2006cites this paper
• Vaccines for preventing influenza in healthy children.

  2006cites this paper
• Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine.

  2005cites this paper
• Patterning of Lectins of Vero and MDCK Cells and Influenza Viruses: The Search for Additional Virus/Cell Interactions

  2005cites this paper
• An improved reverse genetics system for influenza A virus generation and its implications for vaccine production.

  2005cites this paper
• Avian Influenza: An Omnipresent Pandemic Threat

  2005cites this paper
• Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).

  2004cites this paper
• Vaccines for preventing influenza in healthy adults.

  2004cites this paper
• Immunostimulant Patch Enhances Immune Responses to Influenza Virus Vaccine in Aged Mice

  2004cites this paper
• Are we ready for universal influenza vaccination in paediatrics?

  2004cites this paper
• Live cold-adapted influenza A vaccine produced in Vero cell line.

  2004cites this paper